Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Nat Biomed Eng ; 3(2): 137-146, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30911429

ABSTRACT

How common polymorphisms in noncoding genome regions can regulate cellular function remains largely unknown. Here we show that cardiac fibrosis, mimicked using a hydrogel with controllable stiffness, affects the regulation of the phenotypes of human cardiomyocytes by a portion of the long noncoding RNA ANRIL, the gene of which is located in the disease-associated 9p21 locus. In a physiological environment, cultured cardiomyocytes derived from induced pluripotent stem cells obtained from patients who are homozygous for cardiovascular-risk alleles (R/R cardiomyocytes) or from healthy individuals who are homozygous for nonrisk alleles contracted synchronously, independently of genotype. After hydrogel stiffening to mimic fibrosis, only the R/R cardiomyocytes exhibited asynchronous contractions. These effects were associated with increased expression of the short ANRIL isoform in R/R cardiomyocytes, which induced a c-Jun N-terminal kinase (JNK) phosphorylation-based mechanism that impaired gap junctions (particularly, loss of connexin-43 expression) following stiffening. Deletion of the risk locus or treatment with a JNK antagonist was sufficient to maintain gap junctions and prevent asynchronous contraction of cardiomyocytes. Our findings suggest that mechanical changes in the microenvironment of cardiomyocytes can activate the regulation of their function by noncoding loci.

2.
J Fam Pract ; 65(6): 412-21, 2016 06.
Article in English | MEDLINE | ID: mdl-27474825

ABSTRACT

Single-agent therapy with a very potent or potent topical corticosteroid appears more effective than other topical agents, including vitamin D3 analogues, for treating scalp psoriasis.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Bone Density Conservation Agents/therapeutic use , Psoriasis/drug therapy , Scalp Dermatoses/drug therapy , Vitamin D/therapeutic use , Administration, Topical , Facial Dermatoses/drug therapy , Humans , Vitamin D/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...